06
06MA.F Materialise NV
- Market cap
- EUR 337M
- P/E
- 26.8x
- P/B
- 1.32x
- ROE
- 3.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 06MA.F undervalued?
Graham number06MA.F trades 25.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Materialise NV fundamental analysis
No fundamental analysis for Materialise NV yet.
Materialise NV stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Materialise NV
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces betwee…
Full company profileMaterialise NV financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Materialise NV annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 114M | 143M | 185M | 197M | 170M | 205M | 232M | 256M | 267M | 268M | 272M |
| Gross Profit | 67.8M | 79.8M | 102M | 110M | 94.0M | 117M | 129M | 145M | 151M | 153M | 156M |
| Operating Income | -345K | 1.10M | 4.73M | 7.02M | -2.89M | 12.2M | -2.87M | 15.0M | 9.43M | 8.94M | 9.30M |
| EBITDA | - | 12.5M | 22.5M | 25.7M | 17.5M | 38.4M | 25.8M | 30.1M | 37.2M | 30.7M | 35.3M |
| Net Income | -3.02M | -1.66M | 3.03M | 1.65M | -7.12M | 13.2M | -2.12M | 6.72M | 13.4M | 7.72M | 8.70M |
| EPS | - | -0.03 | 0.06 | 0.03 | -0.13 | 0.22 | -0.04 | 0.11 | 0.23 | 0.13 | 0.15 |
| Balance Sheet | |||||||||||
| Total Assets | 162M | 238M | 313M | 349M | 328M | 413M | 411M | 397M | 396M | 421M | 430M |
| Total Liabilities | 82.9M | 160M | 177M | 207M | 195M | 181M | 182M | 160M | 148M | 165M | 174M |
| Shareholders' Equity | 79.0M | 77.5M | 136M | 140M | 133M | 233M | 229M | 237M | 249M | 256M | 256M |
| Cash & Short-term Investments | 55.9M | 43.2M | 116M | 129M | 112M | 196M | 141M | 128M | 102M | 134M | 154M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 8.50M | 9.95M | 28.3M | 28.4M | 30.0M | 25.8M | 22.3M | 18.7M | 31.5M | 25.3M | 33.0M |
| Capital Expenditure | 14.6M | 27.7M | 18.3M | 13.5M | 11.0M | 7.93M | 21.6M | 14.6M | 26.4M | 16.3M | 7.45M |
| Free Cash Flow | - | -22.1M | 8.21M | 12.7M | 12.3M | 14.1M | -64.0K | 4.07M | 5.08M | 9.06M | 25.5M |
| Ratios | |||||||||||
| ROE | -3.8% | -2.1% | 2.2% | 1.2% | -5.4% | 5.7% | -0.9% | 2.8% | 5.4% | 3.0% | 3.4% |
| ROA | -1.9% | -0.7% | 1.0% | 0.5% | -2.2% | 3.2% | -0.5% | 1.7% | 3.4% | 1.8% | 2.0% |
| Net Profit Margin | -2.6% | -1.2% | 1.6% | 0.8% | -4.2% | 6.4% | -0.9% | 2.6% | 5.0% | 2.9% | 3.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Materialise NV dividends
Materialise NV has not paid dividends in the last 9 fiscal years.
Who owns Materialise NV
- Insiders 5.31%
- Institutions 14.50%
- Public & others 80.20%
- Shares outstanding 57.1M
- Free float 22.9M
Materialise NV company profile
- Company name
- Materialise NV
- Ticker
- 06MA.F
- Exchange
- Frankfurt Exchange
- Sector
- Technology
- Industry
- Software
- Employees
- 2,556
- Fiscal year end
- December
- Address
- Technologielaan 15, Leuven, Belgium, 3001
- Phone
- 32 1 639 66 11
- Website
- materialise.com
About Materialise NV
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Materialise NV management
10- Mr. Wilfried VancraenFounder & Chairman · born 1962
- Ms. Brigitte de Vet-VeithenChief Executive Officer · born 1972
- Mr. Koen BergesChief Financial Officer · born 1976
- Mr. Johan PauwelsExecutive VP & COO · born 1968
- Mr. Bart Van der SchuerenChief Strategy & Technology Officer and Executive VP · born 1968
- Ms. Carla Van SteenbergenExecutive Vice President, Director of Corporate Affairs, Compliance Officer & Secretary · born 1977
- Ms. Annelies MissottenChief Human Resources Officer · born 1973
- Mr. Jurgen LaudusExecutive Vice President of Manufacturing · born 1979
- Mr. Udo EberleinExecutive Vice President of Software · born 1969
- Mr. Philippe VerlindeChief Digital Information Officer · born 1964